• General Virology
• 46 min
  1. Principles of virology

  • Prof. Vincent Racaniello
• 36 min
  2. The type I interferon system and viruses

  • Dr. Adolfo Garcia-Sastre
• 45 min
  3. Immune responses to viruses

  • Prof. Paul Klenerman
• Emerging Pathogens
• 29 min
  4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 37 min
  5. Emerging respiratory viruses - discoveries between 2001 and 2005

  • Prof. Ron Fouchier
• 28 min
  6. Usage of vaccines and therapeutics in public health emergencies 1

  • Prof. Gary Kobinger
• 39 min
  7. Usage of vaccines and therapeutics in public health emergencies 2

  • Prof. Gary Kobinger
• 50 min
  8. Influenza virus pandemics: past and future

  • Prof. Peter Palese
• 63 min
  9. SARS-CoV and other emerging coronaviruses

  • Prof. Ralph Baric
• 36 min
  10. Dengue, Zika and Chickungunya viruses

  • Prof. Ana Fernandez-Sesma
• 43 min
  11. Paramyxoviruses: biology & pathogenesis

  • Prof. Benhur Lee
• 36 min
  12. Antiviral drugs (non-HIV)

  • Prof. Megan Shaw
• 41 min
  13. Biodefense challenges

  • Dr. David Franz
• Important Pathogens and their Diseases
• 38 min
  14. Natural history and pathogenesis of herpes virus infections

  • Prof. Richard Whitley
• 40 min
  15. Cytomegalovirus biology

  • Prof. Domenico Tortorella
• 46 min
  16. Hepatitis C virus: discovery, cure and protection

  • Dr. Matthew Evans
• 32 min
  17. Fundamentals of HIV biology

  • Prof. Viviana Simon
• 44 min
  18. Measles

  • Prof. Diane E. Griffin
• 42 min
  19. Monkeypox virus, vaccines, and therapeutics

  • Prof. Rachel Roper
• New Frontiers
• 45 min
  20. HPV vaccines to prevent cervical cancer and other HPV-associated diseases

  • Dr. John Schiller
• 55 min
  21. Prevention of Varicella and Zoster by vaccination: Now you see it, now you don't

  • Prof. Anne Gershon
• 30 min
  22. Viruses as anticancer weapons

  • Prof. Roberto Cattaneo
• 48 min
  23. Novel approaches to diagnosis of viral infections

  • Prof. W. Ian Lipkin
• 36 min
  24. The Global Virus Network: collaboration to address pandemic and regional threats

  • Prof. Sten H. Vermund
• 31 min
  25. Elite controllers of HIV: from discovery to future therapies

  • Prof. Bruce Walker
• Archived Lectures *These may not cover the latest advances in the field
• 43 min
  26. Principles of virology I

  • Prof. Richard Condit
• 43 min
  27. Principles of virology II

  • Prof. Richard Condit
• 36 min
  28. Complex DNA viruses: herpes virus

  • Dr. John Blaho
• 38 min
  29. Adeno-associated viruses (AAV)

  • Prof. Kenneth Berns
• 60 min
  30. Poxviruses: smallpox (variola), vaccinia and monkeypox

  • Prof. Paula Traktman
• 26 min
  31. Can HPV testing be the sole primary cervical screening modality?

  • Prof. Jack Cuzick
• 29 min
  32. From viruses to oncolytics

  • Prof. Roberto Cattaneo
• 38 min
  33. Non HIV antivirals

  • Prof. Mary Klotman
• 42 min
  34. Gastroenteritis viruses

  • Prof. Mary Estes
• 46 min
  35. Biodefense challenges

  • Dr. Connie Schmaljohn
• 32 min
  36. Papillomaviruses and HPV vaccination to prevent cervical cancer and other HPV-associated diseases

  • Dr. Douglas Lowy
• 49 min
  37. The past, present and future of vaccination

  • Prof. Stanley Plotkin
• 41 min
  38. Filoviruses

  • Dr. Christopher Basler
• 41 min
  39. Bunyaviruses

  • Prof. Richard Elliott
• 41 min
  40. The immunobiology of HIV

  • Prof. Norman Letvin
• 59 min
  41. Hepatitis C and HCV

  • Prof. Stanley Lemon

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Age-specific mortality rates
3. UK audit - cases
4. Role of HPV testing in cervical screening (1)
5. Role of HPV testing in cervical screening (2)
6. "HPV testing is at least as good"
7. Baseline results of HPV testing
8. Aims
9. Studies included
10. HPV positivity by age - common shape
11. Cytology sensitivity - CIN2+ (all ages)
12. HPV sensitivity - CIN2+ (all ages)
13. Cytology positivity - normal (all ages)
14. HPV positivity - normal (all ages)
15. HPV positivity - normal (ages = or more than 35)
16. Summary
17. Subsequent studies
18. Double-testing studies after overview
19. Randomised trials - first round
20. Long-term follow-up of HPV testing
21. Cumulative incidence of CIN2+
22. Cumulative incidence rate for CIN3+
23. Conclusions
24. Proposed new screening algorithm
25. HPV typing
26. mRNA testing
27. Other potential adjunctive tests
28. Potential future screening algorithm

Topics Covered

• Cases of cervical cancer in the UK
• Potential role of HPV testing in cervical screening
• Baseline results of HPV testing in European and North American screening studies
• HPV positivity by age
• Cytology sensitivity and positivity
• HPV sensitivity and positivity
• Double-testing studies
• Randomized trials
• Long-term follow-up of HPV testing: results from the Hammersmith study
• Proposed new screening algorithm
• HPV typing
• mRNA testing
• Other potential adjunctive tests
• Potential future screening algorithm

Links

Series:

• Viruses and Viral Diseases

Categories:

• Clinical Practice
• Methods
• Microbiology
• Reproduction & Development

Therapeutic Areas:

• Gynaecology & Obstetrics
• Infectious Diseases

Talk Citation

Publication History

• Published on July 15, 2010
• Archived on December 31, 2017

Financial Disclosures

• Prof. Jack Cuzick has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.